132 related articles for article (PubMed ID: 12063922)
1. [Muir-Torre syndrome].
Jonas J; Kruse R; Bähr R
Chirurg; 2002 Apr; 73(4):366-9. PubMed ID: 12063922
[TBL] [Abstract][Full Text] [Related]
2. [Muir-Torre syndrome and familial colorectal cancer: 2 families with molecular genetic analysis].
Doré MX; Dieumegard B; Grandjouan S; Avril MF; Martinet C; Ducreux M; Lasser P; Bressac-de Paillerets B
Ann Dermatol Venereol; 1999; 126(8-9):582-6. PubMed ID: 10530344
[TBL] [Abstract][Full Text] [Related]
3. [Mutation in the MSH2 gene in Muir-Torre syndrome].
Godard V; Coulet F; Bernaudin JF; Housset M; Soubrier F
Ann Dermatol Venereol; 1999; 126(8-9):600-3. PubMed ID: 10530347
[TBL] [Abstract][Full Text] [Related]
4. Colorectal cancer and the Muir-Torre syndrome in a Gypsy family: a review.
Lynch HT; Leibowitz R; Smyrk T; Fusaro RM; Lynch JF; Smith A; Franklin B; Stella A; Liu B
Am J Gastroenterol; 1999 Mar; 94(3):575-80. PubMed ID: 10086635
[TBL] [Abstract][Full Text] [Related]
5. The Muir-Torre syndrome: a rare variant of hereditary nonpolyposis colorectal cancer associated with hMSH2 mutation.
Suspiro A; Fidalgo P; Cravo M; Albuquerque C; Ramalho E; Leitão CN; Costa Mira F
Am J Gastroenterol; 1998 Sep; 93(9):1572-4. PubMed ID: 9732950
[TBL] [Abstract][Full Text] [Related]
6. Identification of Muir-Torre syndrome among patients with sebaceous tumors and keratoacanthomas: role of clinical features, microsatellite instability, and immunohistochemistry.
Ponti G; Losi L; Di Gregorio C; Roncucci L; Pedroni M; Scarselli A; Benatti P; Seidenari S; Pellacani G; Lembo L; Rossi G; Marino M; Lucci-Cordisco E; Ponz de Leon M
Cancer; 2005 Mar; 103(5):1018-25. PubMed ID: 15662714
[TBL] [Abstract][Full Text] [Related]
7. Different phenotypes in Muir-Torre syndrome: clinical and biomolecular characterization in two Italian families.
Ponti G; Ponz de Leon M; Losi L; Di Gregorio C; Benatti P; Pedroni M; Scarselli A; Riegler G; Lembo L; Pellacani G; Seidenari S; Rossi G; Roncucci L
Br J Dermatol; 2005 Jun; 152(6):1335-8. PubMed ID: 15949004
[TBL] [Abstract][Full Text] [Related]
8. Novel germline hMSH2 genomic deletion and somatic hMSH2 mutations in a hereditary nonpolyposis colorectal cancer family.
Miyaki M; Iijima T; Yamaguchi T; Shirahama S; Ito T; Yasuno M; Mori T
Mutat Res; 2004 Apr; 548(1-2):19-25. PubMed ID: 15063132
[TBL] [Abstract][Full Text] [Related]
9. A Muir-Torre syndrome family.
Serleth HJ; Kisken WA
Am Surg; 1998 Apr; 64(4):365-9. PubMed ID: 9544152
[TBL] [Abstract][Full Text] [Related]
10. Cystic sebaceous tumors as marker lesions for the Muir-Torre syndrome: a histopathologic and molecular genetic study.
Rütten A; Burgdorf W; Hügel H; Kutzner H; Hosseiny-Malayeri HR; Friedl W; Propping P; Kruse R
Am J Dermatopathol; 1999 Oct; 21(5):405-13. PubMed ID: 10535567
[TBL] [Abstract][Full Text] [Related]
11. [Clinical follow-up and presence of visceral tumors in 12 patients with sebaceous gland tumors].
Mercader P; García-Melgares ML; Roche E; Sánchez-Carazo JL; Alegre-de Miquel V
Actas Dermosifiliogr; 2008 Sep; 99(7):532-9. PubMed ID: 18682166
[TBL] [Abstract][Full Text] [Related]
12. [Muir-Torre syndrome].
Lòngy M
Ann Dermatol Venereol; 1999; 126(8-9):580-1. PubMed ID: 10530343
[No Abstract] [Full Text] [Related]
13. A case of Muir-Torre syndrome associated with mucinous hepatic cholangiocarcinoma and a novel germline mutation of the MSH2 gene.
Vernez M; Hutter P; Monnerat C; Halkic N; Gugerli O; Bouzourene H
Fam Cancer; 2007; 6(1):141-5. PubMed ID: 17051350
[TBL] [Abstract][Full Text] [Related]
14. Microsatellite instability in Muir-Torre syndrome.
Honchel R; Halling KC; Schaid DJ; Pittelkow M; Thibodeau SN
Cancer Res; 1994 Mar; 54(5):1159-63. PubMed ID: 8118799
[TBL] [Abstract][Full Text] [Related]
15. The frequency of Muir-Torre syndrome among Lynch syndrome families.
South CD; Hampel H; Comeras I; Westman JA; Frankel WL; de la Chapelle A
J Natl Cancer Inst; 2008 Feb; 100(4):277-81. PubMed ID: 18270343
[TBL] [Abstract][Full Text] [Related]
16. New mutation in the hMSH2 gene in a Spanish Muir-Torre syndrome.
Caldés T; Godino J; Perez-Segura P; de la Hoya M; Diaz-Rubio E; Benito M
Am J Gastroenterol; 2000 Sep; 95(9):2389-90. PubMed ID: 11007253
[No Abstract] [Full Text] [Related]
17. [Recognising hereditary non-polyposis colorectal cancer without a clear family history].
de Bruin JH; Nagengast FM; Ligtenberg MJ; van Krieken JH; Niermeijer MF; Hoogerbrugge N
Ned Tijdschr Geneeskd; 2004 Oct; 148(42):2053-7. PubMed ID: 15532325
[TBL] [Abstract][Full Text] [Related]
18. Widespread microsatellite instability in sebaceous tumours of patients with the Muir-Torre syndrome.
Peris K; Onorati MT; Keller G; Magrini F; Donati P; Muscardin L; Höfler H; Chimenti S
Br J Dermatol; 1997 Sep; 137(3):356-60. PubMed ID: 9349329
[TBL] [Abstract][Full Text] [Related]
19. The importance of functional testing in the genetic assessment of Muir-Torre syndrome, a clinical subphenotype of HNPCC.
Ollila S; Fitzpatrick R; Sarantaus L; Kariola R; Ambus I; Velsher L; Hsieh E; Andersen MK; Raevaara TE; Gerdes AM; Mangold E; Peltomäki P; Lynch HT; Nyström M
Int J Oncol; 2006 Jan; 28(1):149-53. PubMed ID: 16327991
[TBL] [Abstract][Full Text] [Related]
20. Molecular analysis of endometrial hyperplasia in HNPCC-suspicious patients may predict progression to endometrial carcinoma.
Sutter C; Dallenbach-Hellweg G; Schmidt D; Baehring J; Bielau S; von Knebel Doeberitz M; Gebert J
Int J Gynecol Pathol; 2004 Jan; 23(1):18-25. PubMed ID: 14668545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
